Bentham Science Logo

Track Your Manuscript:


Current Pharmacogenomics and Personalized Medicine

Formerly: Current Pharmacogenomics

Volume 17, 3 Issues, 2020
ISSN: 1875-6913 (Online)
ISSN: 1875-6921 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Aims & Scope

Current Pharmacogenomics and Personalized Medicine (CPPM) is a transdisciplinary, peer-reviewed, biomedical journal that reports new findings and cutting-edge concepts in all areas of pharmacology. Special consideration is given to articles on pharmacogenomics and personalized medicine. CPPM is an accelerator for global personalized medicine and pharmacogenomics, as well as preclinical and clinical pharmacology. Importantly, the journal provides a multi-disciplinary, integrated platform from cell to society to address diagnostics and responsible pharmacogenomics applications in developing countries and the entire range of translational science from bench-to-bedside in various therapeutic areas such as oncology, cardiovascular, neuropharmacology, endocrine diseases, amongst others.

CPPM cooperates with the Ibero-American Network of Pharmacogenetics and the Pacific Rim Association for Clinical Pharmacogenetics and welcomes peer reviewed contributions from authors in any global region.

The journal's scope is defined by four inter-connected aims. First, we are interested in genomics/postgenomics biotechnologies and diagnostics that enable global personalized medicine science (including and beyond pharmacogenomics), as long as they explain person-to-person and population differences in disease susceptibility or response to a health intervention, and can be substantiated. Second, we approach personalized medicine as ‘personalized health interventions’ focusing primarily on drug therapy, but also other interventions such as nutrition, vaccines, surgical devices, emerging cell-based therapies that collectively contribute to healthcare. Third, we strive to integrate molecular and clinical investigation with public policy, global health diplomacy and social studies of biotechnology, that collectively shape postgenomics future(s) and innovation trajectories in life sciences. Fourth, we are interested in all aspects of translational pharmacology from preclinical to clinical applications in any therapeutic area that will advance the practice of medicine for the benefit of patients worldwide including non-communicable diseases as well as infectious diseases in the post- COVID world.

Priority will be given to expert reviews/ mini-reviews and research articles that include original ideas and findings related to the scope and mandate of the journal. Unsolicited submissions are welcomed.

Current Pharmacogenomics and Personalized Medicine

,

Volume 17

-

Number 2



Biography   Open Access



Editorial   Open Access



Review Article



Review Article



Review Article



Research Article

Genomics and Pharmacogenomics of Rhinosinusitis

, 17(2): 114 - 124

Joaquin Guerra*, Juan Carlos Carril, Margarita Alcaraz, Marcos Santiago, Lola Corzo and Ramon Cacabelos


DOI: 10.2174/1875692117999200801024849


Research Article



Research Article



Articles Ahead of Print

Novel Somatic Mutations of the CDH1 Gene Associated with Gastric Cancer: Prediction of Pathogenicity Using Comprehensive In silico Methods


Payel Chakraborty, Souvik Ghatak, Ravi Prakash Yadav, Subhajit Mukherjee, Lalchhandama Chhakchhuak, Saia Chenkual, Thomas Zomuana, Sailo Tlau Lalruatfela, Arindam Maitra and Nachimuthu Senthil Kumar*


DOI: 10.2174/1875692117999201109210911
View Abstract



Abstracts Ahead of Print

There are currently no Abstracts Ahead of Print available for this journal.

Published Contents

Editor's Choice

Association of FOXP3 Polymorphisms with Susceptibility to Multiple Sclerosis: A Meta-Analysis on Genetic Association Studies

, 2020; 17(2): 94 - 103

Nazanin Mousavi, Seyyed Amir Yasin Ahmadi, Zahra Mahmoudi, Reza Nekouian, Bijan Ansari-moghaddam and Farhad Shahsavar*


DOI: 10.2174/1875692118666200122163559






The Gut Microbiota in Cardiovascular Diseases: From Biomarkers and Potential Targets to Personalized Interventions

, 2018; 16(1): 75 - 85

Yaroslav I. Ashikhmin, Abram L. Syrkin, Andrey A. Zamyatnin Jr.*, Yong Zhang and Philipp Yu. Kopylov*


DOI: 10.2174/1875692116666180511170329




Cardiovascular Pharmacogenomics

, 2017; 15(1): 67 - 80

Valentina Manzo*, Sara Tarallo, Teresa Iannaccone, Maria Costantino, Walter Filippelli and Amelia Filippelli


DOI: 10.2174/1875692115666170503124456



Gender Differences in Response to Therapy for Cardiovascular Diseases

, 2017; 15(1): 14 - 26

Corbi Graziamaria*, Ambrosino Immacolata, Komici Klara, Cellurale Michele, Lombardi Anna and Ferrara Nicola


DOI: 10.2174/1875692115666170508153322



Allele Frequencies of CYP2D6, CYP3A5 and DPYD Genes Polymorphisms in the Healthy Yakut Population

, 2016; 14(1): 50 - 55

Filipp F. Vasilyev, Diana A. Danilova, Vladimir S. Kaimonov, Yana V. Chertovskih and Nadezda R. Maksimova


DOI: 10.2174/1875692114666160801151257




Open Access Articles

HLA-B27 is a Risk Factor for Rheumatoid Arthritis: Suggestion for an Evidence-based Update

, 2020; 17(1): 7 - 10

Seyyed Amir Yasin Ahmadi, Reza Mohammadrezaei-Khorramabadi, Saber Abbaszadeh, Jafar Rezaian and Farhad Shahsavar*






Mutation Analysis of ABL1 Gene and its Relation to the Achievement of Major Molecular Response in Indonesian Chronic Myeloid Leukemia Patients

, 2020; 17(1): 48 - 54

Reni Widyastuti, Melva Louisa, Ikhwan Rinaldi*, Riki Nova , Instiaty Instiaty and Rizky Priambodo




Genetic Polymorphisms of CYP2D6: Prevalence in Healthy Kurds

, 2020; 17(1): 40 - 47

Muslih Abdulkarim Ibrahim*, Zalina Zahari*, Nurfadhlina Musa and Khoo Boon Yin




Peculiaritie of Distribution of Polymorphic Variants of IL1Β Gene in Patients with Atherosclerosis and Metabolic Syndrome

, 2020; 17(1): 32 - 39

Saranchina Y. Vladimirovna*, Rossova N. Aleksandrovna, Khanarin N. Vladimirovich, Kilina O. Yur'evna, Dutova S. Vyacheslavovna and Kulakova T. Sergeevna







Molecular Mechanism of Metformin Associated Lactic Acidosis (MALA)- an In Silico Exploration

, 2018; 16(3): 199 - 209

Siddiqur Rahman, Tamim Ahsan, Riajul Hossain, Tasnim Ahmed and Abu Ashfaqur Sajib*




Metabolomics-based Approach to Pharmacotherapy Personalization: Advantages and Limitations

, 2018; 16(3): 192 - 198

Dmitry L. Maslov*, Elena E. Balashova, Oxana P. Trifonova and Petr G. Lokhov






Individualized Cancer Therapy, Future Approaches

, 2018; 16(2): 156 - 163

Da-Yong Lu*, Ting-Ren Lu, Bin Xu, Jin-Yu Che, Ying Shen and Nagendra Sastry Yarla






Most Cited Articles



Research Article

In silico study of potential cross-kingdom plant microRNA based regulation in chronic myeloid leukemia

, 2020; 17(2): 125-132.

Marjanu Hikmah Elias*, Noraziah Nordin and Nazefah Abdul Hamid


DOI: 10.2174/1875692118666200106113610


Review Article

Association of FOXP3 polymorphisms with susceptibility to multiple sclerosis: A meta-analysis on genetic association studies

, 2020; 17(2): 94-103.

Nazanin Mousavi, Seyyed Amir Yasin Ahmadi, Zahra Mahmoudi, Reza Nekouian, Bijan Ansari-moghaddam and Farhad Shahsavar*


DOI: 10.2174/1875692118666200122163559




Research Article

Genomics and pharmacogenomics of rhinosinusitis

, 2020; 17(2): 114-124.

Joaquin Guerra*, Juan Carlos Carril, Margarita Alcaraz, Marcos Santiago, Lola Corzo and Ramon Cacabelos


DOI: 10.2174/1875692117999200801024849




Research Article

Mutation analysis of ABL1 gene and its relation to the achievement of major molecular response in Indonesian chronic myeloid leukemia patients

, 2020; 17(1): 48-54.

Reni Widyastuti, Melva Louisa, Ikhwan Rinaldi*, Riki Nova , Instiaty Instiaty and Rizky Priambodo


DOI: 10.2174/1875692117666190925115852


Research Article

Genetic polymorphisms of CYP2D6: Prevalence in healthy kurds

, 2020; 17(1): 40-47.

Muslih Abdulkarim Ibrahim*, Zalina Zahari*, Nurfadhlina Musa and Khoo Boon Yin


DOI: 10.2174/1875692117666190416145331


Editorial

Hla-b27 is a risk factor for rheumatoid arthritis: Suggestion for an evidence-based update

, 2020; 17(1): 7-10.

Seyyed Amir Yasin Ahmadi, Reza Mohammadrezaei-Khorramabadi, Saber Abbaszadeh, Jafar Rezaian and Farhad Shahsavar*


DOI: 10.2174/1875692117666190408113012


Research Article

Peculiaritie of distribution of polymorphic variants of il1Β gene in patients with atherosclerosis and metabolic syndrome

, 2020; 17(1): 32-39.

Saranchina Y. Vladimirovna*, Rossova N. Aleksandrovna, Khanarin N. Vladimirovich, Kilina O. Yur'evna, Dutova S. Vyacheslavovna and Kulakova T. Sergeevna


DOI: 10.2174/1875692117666190416150346





Most Accessed Articles




Transcriptional Analysis of JAK/STAT Signaling in Glioblastoma Multiforme

, 2012; 10(1): 54-69.

Rekha Jain, Asmita Dasgupta, Aliasgar Moiyadi and Sanjeeva Srivastava


DOI: 10.2174/1875692111201010054




Pharmacogenetics Research Developments in Africa: A Focus on Malawi

, 2012; 10(1): 87-97.

Elizabeth Kampira, Johnstone Kumwenda, Joep J. van Oosterhout, Mas Chaponda and Collet Dandara


DOI: 10.2174/1875692111201010087






Editor-in-Chief

Ramón Cacabelos
International Center of Neuroscience and Genomic Medicine
EuroEspes Biomedical Research Center
15165-Corunna
(Spain)
Biography
View Full Editorial Board

COPE Compliant

Journal History

Current Pharmacogenomics was launched in 2003 and later renamed in 2008 as Current Pharmacogenomics and Personalized Medicine.

Related Journals

Related eBooks

eBooks Catalog